Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 1
1982 4
1983 2
1984 2
1985 12
1986 21
1987 31
1988 38
1989 38
1990 32
1991 57
1992 27
1993 34
1994 43
1995 49
1996 58
1997 49
1998 63
1999 51
2000 72
2001 70
2002 71
2003 73
2004 79
2005 75
2006 91
2007 84
2008 57
2009 56
2010 59
2011 56
2012 61
2013 70
2014 54
2015 50
2016 68
2017 46
2018 48
2019 46
2020 45
2021 62
2022 56
2023 46
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

1,985 results

Results by year

Filters applied: . Clear all
Page 1
Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway.
Xiu AY, Ding Q, Li Z, Zhang CQ. Xiu AY, et al. Drug Des Devel Ther. 2021 Aug 21;15:3643-3659. doi: 10.2147/DDDT.S317701. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34456560 Free PMC article.
In vitro, the human HSC cell line LX-2 was cultured and treated with different doses of doxazosin for the indicated times. The effects of doxazosin on LX-2 cell proliferation and migration were examined by Cell Counting Kit-8 (CCK-8) and Transwell assays, respective …
In vitro, the human HSC cell line LX-2 was cultured and treated with different doses of doxazosin for the indicated times. The effect …
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM Jr, Clarke HS, Crawford ED, Diokno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM, Smith JA; Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. McConnell JD, et al. N Engl J Med. 2003 Dec 18;349(25):2387-98. doi: 10.1056/NEJMoa030656. N Engl J Med. 2003. PMID: 14681504 Free article. Clinical Trial.
The reduction in risk associated with combination therapy (66 percent for the comparison with placebo, P<0.001) was significantly greater than that associated with doxazosin (P<0.001) or finasteride (P<0.001) alone. The risks of acute urinary retention and the nee …
The reduction in risk associated with combination therapy (66 percent for the comparison with placebo, P<0.001) was significantly greater …
Doxazosin and congestive heart failure.
Sica DA. Sica DA. Congest Heart Fail. 2002 May-Jun;8(3):178-84. doi: 10.1111/j.1527-5299.2002.00939.x. Congest Heart Fail. 2002. PMID: 12045387 Free article. Review.
Doxazosin remains a commonly used antihypertensive medication, although its use has been tainted by recent findings from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ...This finding was largely driven by congestive heart failure …
Doxazosin remains a commonly used antihypertensive medication, although its use has been tainted by recent findings from the Antihype …
Doxazosin as combination therapy for patients with stage 1 and stage 2 hypertension.
Black HR. Black HR. J Cardiovasc Pharmacol. 2003 Jun;41(6):866-9. doi: 10.1097/00005344-200306000-00006. J Cardiovasc Pharmacol. 2003. PMID: 12775963 Review.
Data extraction was based on the tolerability and efficacy data of doxazosin in patients with hypertension. Compared with placebo, doxazosin combination therapy leads to significant improvements in sitting and standing blood pressure. ...The positive effects of d …
Data extraction was based on the tolerability and efficacy data of doxazosin in patients with hypertension. Compared with placebo, …
Doxazosin for benign prostatic hyperplasia in primary care.
Guthrie R. Guthrie R. Clin Ther. 1997 Nov-Dec;19(6):1269-77; discussion 1253-4. doi: 10.1016/s0149-2918(97)80004-5. Clin Ther. 1997. PMID: 9444439 Review.
Doxazosin can be given in a convenient once-daily dose, and its efficacy is maintained in the long term. Patients with BPH who are already being treated for hypertension with doxazosin need no alteration in their dosage regimen, and doxazosin can be used as a …
Doxazosin can be given in a convenient once-daily dose, and its efficacy is maintained in the long term. Patients with BPH who are al …
Doxazosin gastrointestinal therapeutic system: a review of its use in benign prostatic hyperplasia.
Goldsmith DR, Plosker GL. Goldsmith DR, et al. Drugs. 2005;65(14):2037-47. doi: 10.2165/00003495-200565140-00008. Drugs. 2005. PMID: 16162024 Review.
Doxazosin, a well established treatment in patients with bothersome lower urinary tract symptoms from benign prostatic hyperplasia (BPH), is available in a new controlled-release formulation, doxazosin gastrointestinal therapeutic system (GITS). ...Doxazosin …
Doxazosin, a well established treatment in patients with bothersome lower urinary tract symptoms from benign prostatic hyperplasia (B …
Doxazosin in elderly patients with hypertension.
Weinberger MH, Fawzy A. Weinberger MH, et al. Int J Clin Pract. 2000 Apr;54(3):181-9. Int J Clin Pract. 2000. PMID: 10829361 Review.
Doxazosin has been shown to be effective in reducing the symptoms of BPH in elderly patients whose blood pressure is well controlled by concomitant antihypertensive medication. ...In addition, doxazosin is administered once daily, either in the morning or the evenin …
Doxazosin has been shown to be effective in reducing the symptoms of BPH in elderly patients whose blood pressure is well controlled …
Doxazosin in the current treatment of hypertension.
Wykretowicz A, Guzik P, Wysocki H. Wykretowicz A, et al. Expert Opin Pharmacother. 2008 Mar;9(4):625-33. doi: 10.1517/14656566.9.4.625. Expert Opin Pharmacother. 2008. PMID: 18312163 Review.
Data extraction was based on articles reporting at least 15 or more patients treated with combination of doxazosin with other antihypertensive drugs. RESULTS/CONCLUSIONS: In these studies doxazosin in either standard or extended-release formulation was added as a se …
Data extraction was based on articles reporting at least 15 or more patients treated with combination of doxazosin with other antihyp …
Doxazosin in the treatment of benign prostatic hypertrophy: an update.
Wilt TJ, MacDonald R. Wilt TJ, et al. Clin Interv Aging. 2006;1(4):389-401. doi: 10.2147/ciia.2006.1.4.389. Clin Interv Aging. 2006. PMID: 18046916 Free PMC article. Review.
We evaluated the efficacy and safety of alpha 1--blocker doxazosin for treatment of lower urinary tract symptoms (LUTS) compatible with benign prostatic hypertrophy (BPH). ...Withdrawals from treatment for any cause were comparable to placebo. Dizziness and fatigue occurre …
We evaluated the efficacy and safety of alpha 1--blocker doxazosin for treatment of lower urinary tract symptoms (LUTS) compatible wi …
Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia.
Fulton B, Wagstaff AJ, Sorkin EM. Fulton B, et al. Drugs. 1995 Feb;49(2):295-320. doi: 10.2165/00003495-199549020-00011. Drugs. 1995. PMID: 7537194 Review.
Doxazosin is a long-acting alpha 1-adrenoceptor antagonist structurally related to prazosin and terazosin. ...Doxazosin appears to be a promising agent in the treatment of urinary symptoms associated with benign prostatic hyperplasia. ...
Doxazosin is a long-acting alpha 1-adrenoceptor antagonist structurally related to prazosin and terazosin. ...Doxazosin appear …
1,985 results

Searches related to "doxazosin"